Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid β-oxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences

Carcinogenesis

Volumn 18, Issue 8, 1997, Pages 1491-1498

  Beier, Konstantin ^a   Völkl, Alfred ^a   Metzger, Christel ^b   Mayer, Doris ^b   Bannasch, Peter ^b   Fahimi, H Dariush ^a  

^a Inst fur Anatomie/Zellbiologie I   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYTOCHROME P450; HYDROLYASE; OXIDOREDUCTASE; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; MALE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACYL-COA OXIDASE; ALKANE 1-MONOOXYGENASE; ANIMALS; BLOTTING, WESTERN; CATALASE; CYTOCHROME P-450 ENZYME SYSTEM; DEHYDROEPIANDROSTERONE; ENZYMES; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICROBODIES; MICROSCOPY, IMMUNOELECTRON; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; URATE OXIDASE;

EID: 2642651083     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.8.1491     Document Type: Article

References (72)

1. Berdanier, C.D., Parente, J.A. and McIntosh, M.K. (1993) Is dehydroepiandrosterone an antiobesity agent? FASEB J., 7, 414-419.
2. vy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res., 39, 1129-1132.
3. Schwartz, A.G. and Tannen, R.H. (1981) Inhibition of 7,12-dimethyl-benz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis, 2, 1335-1337.
4. Weber, E., Moore, M.A. and Bannasch, P. (1988) Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal in lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Carcinogenesis, 9, 1191-1195.
5. Rao, M.S., Subbarao, V., Yeldandi, A.V. and Reddy, J.K. (1992) Inhibition of spontaneous testicular Leydig cell tumor development in F-344 rats by dehydroepiandrosterone. Cancer Lett., 65, 123-126.
6. McCormick, D.L., Rao, K.V., Johnson, W.D., Bowman-Gram, T.A., Steele, V.E., Lubet, R.A. and Kellof, G.J. (1996) Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res., 56, 1724-1726.
7. Gordon, G.B., Shantz, L.M. and Talalay, P. (1987) Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Adv. Enzyme Regul., 26, 355-382.
8. Rao, M.S., Subbarao, V., Kumar, S., Yeldandi, A.V. and Reddy, J.K. (1992) Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. Japan. J. Cancer Res., 83, 1179-1183.
9. Rao, M.S., Subbarao, V., Yeldandi, A.V. and Reddy, J.K. (1992) Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res., 52, 2977-2979.
10. Metzger, C., Mayer, D., Hoffmann, H., Bocker, T., Hobe, G., Benner, A. and Bannasch, P. (1995) Sequential appearance and ultrastructure of amphophilic cell foci, adenomas and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone (DHEA). Toxicol. Pathol., 23, 591-605.
11. LAw) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator. Cancer Res., 49, 2337-2343.
12. Prough, R.A., Webb, S.J., Wu, H.Q., Lapenson, D.P. and Waxman, D.J. (1994) Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res., 54, 2878-2886.
13. 2+-channel blockers. Biochem. J., 301, 753-758.
14. Frenkel, R.A., Slaughter, C.A., Orth, K. et al. (1990) Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J. Steroid Biochem., 35, 333-342.
15. Yamada, J., Sakuma, M., Ikeda, T., Fukuda, K. and Suga, T. (1991) Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim. Biophys. Acta, 1092, 233-243.
16. Bellei, M., Battelli, D., Fornieri, C., Mori, G., Muscatello, U., Lardy, H. and Bobyleva, V. (1992) Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone. J. Nutr., 122, 967-976.
17. Rao, M.S., Ide, H., Alvares, K., Subbarao, V., Reddy, J.K., Hechter, O. and Yeldandi, A.V. (1993) Comparative effects of dehydroepiandrosterone and related steroids on peroxisome proliferation in rat liver. Life Sci., 52, 1709-1716.
18. Hayashi, K., Tamura, H., Yamada, J., Kasai, H. and Suga, T. (1994) Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis, 15, 2215-2219.
19. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
20. Gottlicher, M., Widmark, E., Li, Q. and Gustafsson, J.A. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA, 89, 4653-4657.
21. Waxman, D.J. (1996) Role of metabolism in the activation of dehydroepinadrosterone as a peroxisome proliferator. J. Endocrinol., 150, S129-S147.
22. Peters, J.M., Zhou, Y.C., Ram, P.A., Lee, S.S.T., Gonzalez, F.J. and Waxman, D.J. (1996) Peroxisome proliferator activated receptor alpha required for gene induction by dehydroepiandrosterone 3 beta sulfate. Mol. Pharmacol., 50(1), 67-74.
23. Baumgart, E., Stegmeier, K., Schmidt, F.H. and Fahimi, H.D. (1987) Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Lab. Invest., 56, 554-564.
24. Beier, K., Völkl, A. and Fahimi, H.D. (1992) Suppression of peroxisomal lipid β-oxidation enzymes by TNF-α. FEBS Lett., 310, 273-276.
25. Beier, K., Völkl, A. and Fahimi, H.D. (1993) The impact of aging on enzyme proteins of rat liver peroxisomes: quantitative analysis by immunoblotting and immunoelectron microscopy. Virchows Archiv. B Cell. Pathol., 63, 139-146.
26. Lindauer, M., Beier, K., Völkl, A. and Fahimi, H.D. (1994) Zonal heterogeneity of peroxisomal enzymes in rat liver: differential induction by three divergent hypolipidemic drugs. Hepatology, 20, 475-486.
27. Svoboda, D., Grady, H. and Azaraoff, D. (1967) Microbodies in experimentally altered cells. J. Cell Biol., 35, 127-152.
28. Fahimi, H.D., Reinicke, A., Sujatta, M., Yokota, S., Özel, M., Hartig, F. and Stegmeier, K. (1982) The short- and long-term effects of bezafibrate in the rat. Ann. NY Acad. Sci., 386, 111-135.
29. Kawashima, Y., Uy-yu, N. and Kozuka, H. (1989) Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. Biochem. J., 261, 595-600.
30. Sugiyama, H., Yamada, J. and Suga, T. (1994) Effects of testosterone, hypophysectomy and growth hormone treatment on clofibrate induction of peroxisomal β-oxidation in female rat liver. Biochem. Pharmacol., 47, 918-921.
31. Leighton, B., Tagliaferro, A.R. and Newsholme, E.A. (1987) The effect of dehydroepiandrosterone acetate on liver peroxisomal enzyme activities of male and female rats. J. Nutr., 117, 1287-1290.
32. Rao, M.S., Reid, B., Ide, H., Subbarao, V. and Reddy, J.K. (1994) Dehydroepiandrosterone-induced peroxisome proliferation in the rat: evaluation of sex differences. Proc. Soc. Exp. Biol. Med., 207, 186-190.
33. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
34. Rao, M.S. and Reddy, J.K. (1987) Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis, 8, 631-636.
35. 2 generating peroxisomal fatty acyl CoA oxidase. Proc. Natl Acad. Sci. USA, 92, 7080-7084.
36. Lehmann, T., Völkl, A. and Fahimi, H.D. (1995) The importance of tissue fixation for light microscopic immunohistochemical localization of peroxisomal proteins: the superiority of Carnoy's fixative over Baker's formalin and Bouin's solution. Histochemistry, 103, 187-195.
37. Fahimi, H.D. (1967) Perfusion and immersion fixation of rat liver with glutaraldehyde. Lab. Invest., 16, 736-750.
38. Fahimi, H.D. (1969) Cytochemical localization of peroxidatic activity of catalase in rat hepatic microbodies (peroxisomes). J. Cell Biol., 43, 275-288.
39. Hiltunen, J.K. (1991) Peroxisomes and β-oxidation of long-chain unsaturated carboxylic acids. Scand. J. Clin. Lab. Invest., 51(Suppl. 204), 33-46.
40. Beier, K., Völkl, A., Hashimoto, T. and Fahimi, H.D. (1988) Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting. Eur. J. Cell. Biol., 46, 383-393.
41. Burnette, W.N. (1981) 'Western blotting': Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radio-iodinated protein A. Analyt. Biochem., 112, 195-203.
42. Beier, K. and Fahimi, H.D. (1987) Application of automatic image analysis for morphometric studies of peroxisomes stained cytochemically for catalase. II Light-microscopic application. Cell Tissue Res., 247, 179-185.
43. Beier, K. and Fahimi, H.D. (1992) Application of automatic image analysis for quantitative morphological studies of peroxisomes in rat liver in conjunction with cytochemical staining with 3-3′ diaminobenzidine and immunocytochemistry. Microsc. Res. Technique, 21, 271-282.
44. Roth, J. (1982) The protein A-gold technique - a qualitative and quantitative approach for antigen localization on thin sections. In Bullock, G.R. and Petrusz, P. (eds) Techniques in Immunocytochemistry. Academic Press, New York, pp. 108-133.
45. Beier, K. and Fahimi, H.D. (1985) Automatic determination of labeling density in protein A-gold immunocytochemical preparations using an image analyzer. Histochemistry, 82, 99-100.
46. Hashimoto, T. (1982) Individual beta-oxidation enzymes. Ann. NY Acad. Sci., 386, 5-12.
47. Yamada, J., Sakuma, M. and Suga, T. (1992) Induction of peroxisomal β-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes. Biochim. Biophys. Acta, 1137, 231-236.
48. van Weerden, W.M., Bierings, H.G., van Steenbrugge, G.J., de Jong, F.H. and Schröder, F.H. (1992) Adrenal glands of mouse and rat do not synthesize androgens. Life Sci., 50, 857-861.
49. Hobe, G., Hillesheim, H.G., Schön, R., Reddersen, G., Knappe, R., Bannasch, P. and Mayer, D. (1994) Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm. Metab. Res., 26, 326-329.
50. Eacho, P.I., Lanier, P.L. and Brodhecker, C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1561.
51. Grasl-Kraupp, B., Huber, W., Timmermann-Trosiener, I. and Schulte-Hermann, R. (1993) Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin. Carcinogenesis, 14, 2435-2437.
52. Barrass, N.C., Price, R.J., Lake, B.G. and Orton, T.C. (1993) Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis, 14, 1451-1456.
53. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis, 16, 1693-1698.
54. Rao, M.S. and Subbarao, V. (1997) Effect of dexamethasone on ciprofibrate induced cell proliferation and peroxisome proliferation. Fund. Appl. Toxicol., 35, 78-83.
55. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 11, 433-439.
56. Zhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1992) Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl Acad. Sci. USA, 89, 7541-7545.
57. Sher, T., Yi, H.F., McBride, O.W. and Gonzalez, F.J. (1993) cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry, 32, 5598-5604.
58. Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G. and Wahli, W. (1993) Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell, 77, 67-76.
59. Zhu, Y.J., Alvares, K., Huang, Q., Rao, M.S. and Reddy, J.K. (1993) Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem., 268, 26817-26820.
60. Marcus, S.L., Miyata, K.S., Zhang, B., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1993) Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl Acad. Sci. USA, 90, 5723-5727.
61. Aldridge, T.C., Tugwood, J.D. and Green, S. (1995) Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J., 306, 473-479.
62. Sharma, R., Lake, B.G., Foster, J. and Gibson, G.G. (1988) Microsomal cytochrome P-452 induction and peroxisomal proliferation by hypolipidaemic agents in rat liver. A mechanistic interrelationship. Biochem. Pharmacol., 37, 1193-1201.
63. Sharma, R., Lake, B.G. and Gibson, G.G. (1988) Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Biochem. Pharmacol., 37, 1203-1206.
64. Lock, E.A., Mitchell, A.M. and Elcombe, C.R. (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol., 29, 145-163.
65. Gibson, G.G. (1989) Comparative aspects of the mammalian cytochrome P450 IV gene family. Xenobiotica, 19, 1123-1148.
66. Kaikaus, R.M., Chan, W.K., Lysenko, N., Ray, R., de Montellano, P.R.O. and Bass, N.M. (1993) Induction of peroxisomal fatty acid β-oxidation and liver fatty acid-binding protein by peroxisome proliferators. Mediation via the cytochrome P-450IVA1 omega-hydroxylase pathway. J. Biol. Chem., 268, 9593-9603.
67. Bocos, C., Göttlicher, M., Gearing, K., Banner, C., Enmark, E., Teboul, M., Crickmore, A. and Gustafsson, J.A. (1995) Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J. Steroid Biochem. Mol. Biol., 53, 467-473.
68. Moody, D.E. and Reddy, J.K. (1976) Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348. J. Cell Biol., 71, 768-780.
69. Gorgas, K. and Krisans, S.K. (1989) Zonal heterogeneity of peroxisome proliferation and morphology in rat liver after gemfibrozil treatment. J. Lipid Res., 30, 1859-1876.
70. Bell, D.R. and Elcombe, C.R. (1991) Induction of acyl-CoA oxidase and cytochrome-P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferates. Biochem. J., 280, 249-253.
71. Bout, A., Deboer, P.A.J., Tager, J.M., Benne, R. and Moorman, A.F.M. (1990) Zonal distribution of peroxisomal 3-oxoacyl-CoA thiolase messenger RNA in liver from rats treated with di-(2-ethylhexyl)phthalate. Biochem. Biophys. Acta, 1055, 240-242.
72. Huang, Q., Yeldandi, A.V., Alvares, K., Ide, H., Reddy, J.K. and Rao, M.S. (1995) Localization of peroxisome proliferator-activated receptor in mouse and rat tissues and demonstration of its nuclear translocation in transfected CV-1 cells. Int. J. Oncol., 6, 307-312.